126 related articles for article (PubMed ID: 30768682)
41. The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma.
Citrin R; Getz KD; Li Y; Huang YS; Horowitz JP; Seif AE; Fisher BT; Aplenc R
Br J Haematol; 2019 Feb; 184(4):684-688. PubMed ID: 29611176
[No Abstract] [Full Text] [Related]
42. Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.
Testi AM; Attarbaschi A; Valsecchi MG; Möricke A; Cario G; Niggli F; Silvestri D; Bader P; Kuhlen M; Parasole R; Putti MC; Lang P; Flotho C; Mann G; Rizzari C; Barisone E; Locatelli F; Linderkamp C; Lauten M; Suttorp M; Zimmermann M; Basso G; Biondi A; Conter V; Schrappe M;
Eur J Cancer; 2019 Nov; 122():61-71. PubMed ID: 31629941
[TBL] [Abstract][Full Text] [Related]
43. High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes.
Nganthavee V; Phutthasakda W; Atipas K; Tanpong S; Pungprasert T; Dhirachaikulpanich D; Krithin S; Tanglitanon S; Jutidamronphang W; Owattanapanich W; Chayakulkeeree M; Phikulsod P
Support Care Cancer; 2019 Sep; 27(9):3613-3622. PubMed ID: 31165931
[TBL] [Abstract][Full Text] [Related]
44. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
[TBL] [Abstract][Full Text] [Related]
45. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
[TBL] [Abstract][Full Text] [Related]
46. Response rate of Pakistani children with acute lymphoblastic leukaemia to Medical Research Council acute lymphoblastic leukaemia 97 chemotherapy protocol.
Idris M; Farid J; Sarwar J; Ahmed S; Wiqar MA; Badsha S
J Ayub Med Coll Abbottabad; 2010; 22(3):8-11. PubMed ID: 22338406
[TBL] [Abstract][Full Text] [Related]
47. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and Predictors of Invasive Fungal Infections in Children with Persistent Febrile Neutropenia Treated for Acute Leukemia - A Prospective Study.
Kumar J; Singh A; Seth R; Xess I; Jana M; Kabra SK
Indian J Pediatr; 2018 Dec; 85(12):1090-1095. PubMed ID: 29956075
[TBL] [Abstract][Full Text] [Related]
49. Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis.
Oh SM; Byun JM; Chang E; Kang CK; Shin DY; Koh Y; Hong J; Kim TS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
Sci Rep; 2021 Nov; 11(1):22160. PubMed ID: 34773060
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH
J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518
[TBL] [Abstract][Full Text] [Related]
51. Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia.
De Pietri S; Frandsen TL; Christensen M; Grell K; Rathe M; Müller K
Pediatr Blood Cancer; 2021 Jan; 68(1):e28793. PubMed ID: 33155402
[TBL] [Abstract][Full Text] [Related]
52. Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers.
Nielsen SN; Eriksson F; Rosthoej S; Andersen MK; Forestier E; Hasle H; Hjalgrim LL; Aasberg A; Abrahamsson J; Heyman M; Jónsson ÓG; Pruunsild K; Vaitkeviciené GE; Vettenranta K; Schmiegelow K
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28500740
[TBL] [Abstract][Full Text] [Related]
53. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
54. [Acute lymphoblastic leukaemia in children and adolescents: chance of cure now higher than 80%].
Pieters R
Ned Tijdschr Geneeskd; 2010; 154():A1577. PubMed ID: 20858304
[TBL] [Abstract][Full Text] [Related]
55. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.
Hakim H; Dallas R; Zhou Y; Pei D; Cheng C; Flynn PM; Pui CH; Jeha S
Cancer; 2016 Mar; 122(5):798-805. PubMed ID: 26700662
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
57. Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
Patrick K; Wade R; Goulden N; Rowntree C; Hough R; Moorman AV; Mitchell CD; Vora A
Br J Haematol; 2014 May; 165(4):552-5. PubMed ID: 24428704
[TBL] [Abstract][Full Text] [Related]
58. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
59. Posaconazole and fluconazole prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia.
Zhang T; Bai J; Huang M; Li R; Liu Y; Liu A; Liu J
J Microbiol Immunol Infect; 2021 Dec; 54(6):1139-1146. PubMed ID: 32828790
[TBL] [Abstract][Full Text] [Related]
60. Infectious profile in children with ALL during chemotherapy: A report of study group for infections.
Zawitkowska J; Drabko K; Szmydki-Baran A; Zaucha-Prażmo A; Lejman M; Czyżewski K; Zalas-Więcek P; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Kulicka E; Semczuk K; Hutnik Ł; Chełmecka-Wiktorczyk L; Klepacka J; Frączkiewicz J; Salamonowicz M; Tomaszewska R; Zając-Spychała O; Irga-Jaworska N; Bień E; Płonowski M; Bartnik M; Ociepa T; Pierlejewski F; Woszczyk M; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Musiał J; Styczyński J
J Infect Chemother; 2019 Oct; 25(10):774-779. PubMed ID: 31101529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
